ncRNA name
hsa-miR-1271
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
Bcl-2
Cancer name
Glioblastoma
Cancer site
Brain, Central Nervous System
Treatment type
Chemotherapy
Drug
Temozolomide
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Up
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Thus, the chemoresistance of GBM cells may be promoted after suppressing miR-1271 through cell survival mediated with Bcl-2.
Tissue resource
clinical samples from patients with glioblastom
human glioblastom cell line A172
Experiment
qRT-PCR,Western blot
Institute
the Affiliated Longhua Central Hospital
American Type Culture Collection
Country
China
USA
Continent
Asia
North American